Published in Int J Cancer on December 15, 2010
Comparison of Cervical Cancer Screening Tests in HIV-infected Women in Lusaka, Zambia | NCT02688816
Durvalumab and Tremelimumab for Adjuvant Therapy of Resected NSCLC | NCT03130764
Role of Oncoplastic Breast Surgery In Breast Cancer Treatement | NCT03273348
Avelumab Plus Carboplatin-gemcitabine in Urothelial Carcinoma | NCT03390595
Gastrectomy Outcomes in Elderly Patients (GOE) | NCT05071755
The mutational landscape of head and neck squamous cell carcinoma. Science (2011) 16.88
Discovery and saturation analysis of cancer genes across 21 tumour types. Nature (2014) 11.68
Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. N Engl J Med (2013) 7.48
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet (2012) 6.65
Genomic landscape of non-small cell lung cancer in smokers and never-smokers. Cell (2012) 6.09
Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial. Lancet (2011) 5.76
The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol (2012) 5.60
Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature (2015) 5.50
14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial. Lancet (2011) 5.21
Integrated molecular analysis of clear-cell renal cell carcinoma. Nat Genet (2013) 4.61
Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst (2011) 4.59
Postoperative radiotherapy for pathologic N2 non-small-cell lung cancer treated with adjuvant chemotherapy: a review of the National Cancer Data Base. J Clin Oncol (2015) 4.58
A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing. Genome Res (2011) 4.15
Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine. J Natl Cancer Inst (2011) 3.92
Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. BMJ (2011) 3.63
Effect of circumcision of HIV-negative men on transmission of human papillomavirus to HIV-negative women: a randomised trial in Rakai, Uganda. Lancet (2011) 3.52
Exposure to bisphosphonates and risk of gastrointestinal cancers: series of nested case-control studies with QResearch and CPRD data. BMJ (2013) 3.34
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial. Lancet Oncol (2013) 3.11
Mutations in BRIP1 confer high risk of ovarian cancer. Nat Genet (2011) 3.06
Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol (2013) 3.00
Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries. Bull World Health Organ (2011) 2.95
Prevention and early detection of prostate cancer. Lancet Oncol (2014) 2.94
Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med (2013) 2.77
Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes. Nat Genet (2012) 2.71
Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer. J Clin Oncol (2013) 2.71
Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network. Br J Cancer (2011) 2.69
Clinicopathological features and surgical treatment of gastric cancer in South Korea: the results of 2009 nationwide survey on surgically treated gastric cancer patients. J Gastric Cancer (2011) 2.59
A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat Rev Microbiol (2012) 2.56
Red and processed meat and colorectal cancer incidence: meta-analysis of prospective studies. PLoS One (2011) 2.55
Outcomes from a prospective trial of endoscopic radiofrequency ablation of early squamous cell neoplasia of the esophagus. Gastrointest Endosc (2011) 2.55
Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res (2014) 2.51
Retracted HMGA2 functions as a competing endogenous RNA to promote lung cancer progression. Nature (2013) 2.47
Impact of occupational carcinogens on lung cancer risk in a general population. Int J Epidemiol (2012) 2.46
Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide. BMJ Open (2013) 2.40
Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma. Cancer Discov (2012) 2.39
Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nat Genet (2014) 2.39
Circadian disrupting exposures and breast cancer risk: a meta-analysis. Int Arch Occup Environ Health (2014) 2.34
First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial. Lancet Oncol (2012) 2.33
Influence of sex on the survival of patients with esophageal cancer. J Clin Oncol (2012) 2.29
Advancing cervical cancer prevention initiatives in resource-constrained settings: insights from the Cervical Cancer Prevention Program in Zambia. PLoS Med (2011) 2.28
Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression. Nat Genet (2012) 2.25
Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium. Ann Oncol (2014) 2.24
Effect of VIA screening by primary health workers: randomized controlled study in Mumbai, India. J Natl Cancer Inst (2014) 2.21
Complete protection against aflatoxin B(1)-induced liver cancer with a triterpenoid: DNA adduct dosimetry, molecular signature, and genotoxicity threshold. Cancer Prev Res (Phila) (2014) 2.20
Achieving high coverage in Rwanda's national human papillomavirus vaccination programme. Bull World Health Organ (2012) 2.20
The effect of benign lower urinary tract symptoms on subsequent prostate cancer testing and diagnosis. Eur Urol (2013) 2.19
Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort. Br J Cancer (2012) 2.15
Fat, fibre and cancer risk in African Americans and rural Africans. Nat Commun (2015) 2.12
HCC and angiogenesis: possible targets and future directions. Nat Rev Clin Oncol (2011) 2.10
Laparoscopic versus open hepatic resection for hepatocellular carcinoma: improvement in outcomes and similar cost. World J Surg (2015) 2.10
Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial. Lancet Oncol (2012) 2.06
Aflatoxin: a 50-year odyssey of mechanistic and translational toxicology. Toxicol Sci (2010) 2.03
Gastric atrophy and xanthelasma are markers for predicting the development of early gastric cancer. J Gastroenterol (2015) 1.98
Denervation suppresses gastric tumorigenesis. Sci Transl Med (2014) 1.96
Coordinate direct input of both KRAS and IGF1 receptor to activation of PI3 kinase in KRAS-mutant lung cancer. Cancer Discov (2013) 1.93
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Res (2013) 1.92
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int (2015) 1.92
Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad. Semin Cancer Biol (2010) 1.91
PIK3R1 (p85α) is somatically mutated at high frequency in primary endometrial cancer. Cancer Res (2011) 1.91
Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis. J Natl Cancer Inst (2013) 1.90
Inherited variation at chromosome 12p13.33, including RAD52, influences the risk of squamous cell lung carcinoma. Cancer Discov (2011) 1.87
Updated evidence in support of diet and exercise interventions in cancer survivors. Acta Oncol (2010) 1.87
Pooled analysis of a self-sampling HPV DNA Test as a cervical cancer primary screening method. J Natl Cancer Inst (2012) 1.86
Obesity and risk of esophageal adenocarcinoma and Barrett's esophagus: a Mendelian randomization study. J Natl Cancer Inst (2014) 1.81
DNA methylation profiling reveals a predominant immune component in breast cancers. EMBO Mol Med (2011) 1.81
Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. PLoS One (2011) 1.80
Tyrosine kinase gene rearrangements in epithelial malignancies. Nat Rev Cancer (2013) 1.80
Comparison of Cancer Incidence between China and the USA. Cancer Biol Med (2012) 1.80
Cancer incidence in Nigeria: a report from population-based cancer registries. Cancer Epidemiol (2012) 1.78
Cancer and radiation therapy: current advances and future directions. Int J Med Sci (2012) 1.76
Tracing the cellular origin of cancer. Nat Cell Biol (2013) 1.75
Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev (2014) 1.73
Mutational landscape of gastric adenocarcinoma in Chinese: implications for prognosis and therapy. Proc Natl Acad Sci U S A (2015) 1.72
Gain-of-function mutant p53 but not p53 deletion promotes head and neck cancer progression in response to oncogenic K-ras. J Pathol (2011) 1.72
EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples. J Clin Pathol (2012) 1.71
Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics. Hepat Med (2012) 1.71
Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity, and prognostic discrimination. Clin Cancer Res (2011) 1.70
Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection. PLoS One (2012) 1.70
Circumcision of HIV-infected men and transmission of human papillomavirus to female partners: analyses of data from a randomised trial in Rakai, Uganda. Lancet Infect Dis (2011) 1.69
Destruction of full-length androgen receptor by wild-type SPOP, but not prostate-cancer-associated mutants. Cell Rep (2014) 1.68
Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer. PLoS One (2012) 1.66
Failure patterns in patients with esophageal cancer treated with definitive chemoradiation. Cancer (2011) 1.66
Molecular genetics of clear-cell renal cell carcinoma. J Clin Oncol (2014) 1.65
Circadian and melatonin disruption by exposure to light at night drives intrinsic resistance to tamoxifen therapy in breast cancer. Cancer Res (2014) 1.65
A long non-coding RNA signature to improve prognosis prediction of colorectal cancer. Oncotarget (2014) 1.64
Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma. Biomed Res Int (2013) 1.63
EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease. Int J Cancer (2012) 1.63
Challenges and possible solutions to colorectal cancer screening for the underserved. J Natl Cancer Inst (2014) 1.61
LncRNAs expression signatures of renal clear cell carcinoma revealed by microarray. PLoS One (2012) 1.59
European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene. Hum Mol Genet (2011) 1.58
Plasma alkylresorcinols, biomarkers of whole-grain wheat and rye intake, and incidence of colorectal cancer. J Natl Cancer Inst (2013) 1.57
Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility. Proc Natl Acad Sci U S A (2013) 1.57
From antimicrobial to anticancer peptides. A review. Front Microbiol (2013) 1.56
Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer. Eur Urol (2015) 1.56
Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer. Sci Rep (2015) 1.55
Oncogenicity of the developmental transcription factor Sox9. Cancer Res (2012) 1.55
A catalyst for change: the European cancer Patient's Bill of Rights. Oncologist (2014) 1.55
Hepatocellular carcinoma screening in a hepatitis B virus-infected Korean population. Dig Dis Sci (2012) 1.55
Meta-analysis of human lung cancer microRNA expression profiling studies comparing cancer tissues with normal tissues. J Exp Clin Cancer Res (2012) 1.55
Global cancer statistics. CA Cancer J Clin (2011) 185.92
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
Global cancer statistics, 2012. CA Cancer J Clin (2015) 53.52
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer (2014) 40.30
Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet (2010) 26.48
Maternal and child undernutrition: global and regional exposures and health consequences. Lancet (2008) 26.44
Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet (2012) 25.96
Global prevalence of dementia: a Delphi consensus study. Lancet (2005) 23.30
Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet (2009) 16.12
Preventing chronic diseases: how many lives can we save? Lancet (2005) 14.77
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol (2010) 9.86
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol (2012) 9.28
International variation in prostate cancer incidence and mortality rates. Eur Urol (2012) 8.04
Chapter 2: The burden of HPV-related cancers. Vaccine (2006) 7.70
Preventing stroke: saving lives around the world. Lancet Neurol (2007) 6.55
Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet (2007) 6.45
Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol (2012) 6.37
The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care (2005) 5.80
Global burden of human papillomavirus and related diseases. Vaccine (2012) 5.48
Violence-related mortality in Iraq from 2002 to 2006. N Engl J Med (2008) 5.43
Nationwide cancer incidence in Korea, 2003-2005. Cancer Res Treat (2009) 5.01
Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer (2008) 5.00
Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet (2012) 4.76
Population-based cancer survival trends in England and Wales up to 2007: an assessment of the NHS cancer plan for England. Lancet Oncol (2009) 4.44
Cancer mortality in India: a nationally representative survey. Lancet (2012) 4.30
Chronic diseases and injuries in India. Lancet (2011) 4.27
Geographic pathology revisited: development of an atlas of cancer in India. Int J Cancer (2005) 4.22
Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer (2002) 4.02
International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer (2005) 3.81
Cancer statistics in Korea: incidence, mortality and survival in 2006-2007. J Korean Med Sci (2010) 3.79
Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness. Eur J Cancer (2009) 3.67
Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality. PLoS Med (2009) 3.42
Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer (2006) 3.38
Sample registration of vital events with verbal autopsy: a renewed commitment to measuring and monitoring vital statistics. Bull World Health Organ (2005) 3.30
Thirty-day postoperative mortality after colorectal cancer surgery in England. Gut (2011) 3.07
Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol (2013) 3.00
Cancer occurrence in Iran in 2002, an international perspective. Asian Pac J Cancer Prev (2005) 2.88
An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews. Am J Gastroenterol (2003) 2.83
A systematic review and meta-analysis of the risk of increasing adiposity on Barrett's esophagus. Am J Gastroenterol (2007) 2.79
Cancer statistics in Korea: incidence, mortality and survival in 2005. J Korean Med Sci (2009) 2.61
The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis. Gastroenterology (2004) 2.59
Optimum duration of regimens for Helicobacter pylori eradication. Cochrane Database Syst Rev (2013) 2.53
50-year mortality trends in children and young people: a study of 50 low-income, middle-income, and high-income countries. Lancet (2011) 2.52
Cancer burden in Africa and opportunities for prevention. Cancer (2012) 2.51
NORDCAN--a Nordic tool for cancer information, planning, quality control and research. Acta Oncol (2010) 2.48
Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding. Cochrane Database Syst Rev (2010) 2.47
The health of aging populations in China and India. Health Aff (Millwood) (2008) 2.37
Burden of disease from inadequate water, sanitation and hygiene in low- and middle-income settings: a retrospective analysis of data from 145 countries. Trop Med Int Health (2014) 2.27
The Y deletion gr/gr and susceptibility to testicular germ cell tumor. Am J Hum Genet (2005) 2.26
Genome-wide linkage screen for testicular germ cell tumour susceptibility loci. Hum Mol Genet (2006) 2.23
National comparisons of lung cancer survival in England, Norway and Sweden 2001-2004: differences occur early in follow-up. Thorax (2010) 2.21
Fifty years of cancer incidence: CI5 I-IX. Int J Cancer (2010) 2.14
Survival trends in European cancer patients diagnosed from 1988 to 1999. Eur J Cancer (2009) 2.12
Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries. J Natl Cancer Inst (2007) 2.08
International trends in the incidence of malignant melanoma 1953-2008--are recent generations at higher or lower risk? Int J Cancer (2012) 2.07
Incidence and mortality of cervical cancer in Latin America. Salud Publica Mex (2003) 2.06
Epidemiological findings of hepatitis B infection based on 1998 National Health and Nutrition Survey in Korea. J Korean Med Sci (2002) 2.03
A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. Carcinogenesis (2002) 1.89
Clonorchis sinensis infection and increasing risk of cholangiocarcinoma in the Republic of Korea. Am J Trop Med Hyg (2006) 1.83
Rising prostate cancer rates in South Korea. Prostate (2006) 1.83
Trends of cervical cancer mortality in the member states of the European Union. Eur J Cancer (2009) 1.80
A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India. Int J Cancer (2005) 1.78
Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys. Cancer Epidemiol Biomarkers Prev (2006) 1.77
Do testicular seminoma and nonseminoma share the same etiology? Evidence from an age-period-cohort analysis of incidence trends in eight European countries. Cancer Epidemiol Biomarkers Prev (2006) 1.75
Breast cancer survival in England, Norway and Sweden: a population-based comparison. Int J Cancer (2010) 1.74
Gastric cancer: epidemiology and risk factors. Gastroenterol Clin North Am (2013) 1.74
A population-based comparison of the survival of patients with colorectal cancer in England, Norway and Sweden between 1996 and 2004. Gut (2011) 1.70
Assessing the impact of drinking water and sanitation on diarrhoeal disease in low- and middle-income settings: systematic review and meta-regression. Trop Med Int Health (2014) 1.64
Helicobacter pylori eradication for the prevention of gastric neoplasia. Cochrane Database Syst Rev (2015) 1.58
WHO and global health monitoring: the way forward. PLoS Med (2010) 1.58
Dyspeptic symptoms and endoscopic findings in the community: the Loiano-Monghidoro study. Am J Gastroenterol (2009) 1.58
Helicobacter pylori infection and gastric cancer--for want of more outcomes. JAMA (2004) 1.57
Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors. Eur J Cancer (2013) 1.57
Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus. Int J Cancer (2003) 1.55
Incidence and mortality from stomach cancer in Japan, Slovenia and the USA. Int J Cancer (2002) 1.51
Global burden of gastric cancer attributable to Helicobacter pylori. Int J Cancer (2014) 1.50
Who to treat with adjuvant therapy in Dukes B/stage II colorectal cancer? The need for high quality pathology. Gut (2007) 1.47
Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis. Am J Gastroenterol (2004) 1.47
Serologic response to oncogenic human papillomavirus types in male and female university students in Busan, South Korea. Cancer Epidemiol Biomarkers Prev (2007) 1.45
Irritable bowel syndrome: a 10-yr natural history of symptoms and factors that influence consultation behavior. Am J Gastroenterol (2008) 1.44
Test characteristics of visual inspection with 4% acetic acid (VIA) and Lugol's iodine (VILI) in cervical cancer screening in Kerala, India. Int J Cancer (2003) 1.43
Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva. Eur J Cancer (2013) 1.42
Preventing chronic disease: a priority for global health. Int J Epidemiol (2006) 1.42
Cancer survival in a southern African urban population. Int J Cancer (2004) 1.41
Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide. Int J Cancer (2014) 1.40
Relation of adult lifestyle and socioeconomic factors to the prevalence of Helicobacter pylori infection. Int J Epidemiol (2002) 1.39
Survival of patients diagnosed with cancer in the Nordic countries up to 1999-2003 followed to the end of 2006. A critical overview of the results. Acta Oncol (2010) 1.36
Polymorphisms in inflammatory response genes and their association with gastric cancer: A HuGE systematic review and meta-analyses. Am J Epidemiol (2010) 1.35
Trends in the incidence of cancer in Qidong, China, 1978-2002. Int J Cancer (2006) 1.35